{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Free Realtime Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": -0.44, "epsForward": -0.37, "epsCurrentYear": -0.63, "priceEpsCurrentYear": -1.1412698, "sharesOutstanding": 98444704, "bookValue": 0.477, "fiftyDayAverage": 0.64432, "fiftyDayAverageChange": 0.07467997, "fiftyDayAverageChangePercent": 0.11590509, "twoHundredDayAverage": 0.64552, "twoHundredDayAverageChange": 0.07348001, "twoHundredDayAverageChangePercent": 0.11383073, "marketCap": 70781744, "forwardPE": -1.9432431, "priceToBook": 1.5073375, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "currency": "SEK", "financialCurrency": "SEK", "regularMarketOpen": 0.713, "averageDailyVolume3Month": 173059, "averageDailyVolume10Day": 89750, "fiftyTwoWeekLowChange": 0.24899998, "fiftyTwoWeekLowChangePercent": 0.5297872, "fiftyTwoWeekRange": "0.47 - 1.12", "fiftyTwoWeekHighChange": -0.40100002, "fiftyTwoWeekHighChangePercent": -0.35803574, "fiftyTwoWeekLow": 0.47, "fiftyTwoWeekHigh": 1.12, "earningsTimestamp": 1683889140, "earningsTimestampStart": 1683889140, "earningsTimestampEnd": 1683889140, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1465282800000, "priceHint": 4, "marketState": "REGULAR", "regularMarketChange": 0.0059999824, "regularMarketTime": 1684139435, "regularMarketDayHigh": 0.719, "regularMarketDayRange": "0.702 - 0.719", "regularMarketDayLow": 0.702, "regularMarketVolume": 5563, "regularMarketPreviousClose": 0.713, "bid": 0.702, "ask": 0.719, "bidSize": 0, "askSize": 0, "fullExchangeName": "Stockholm", "regularMarketChangePercent": 0.84151226, "regularMarketPrice": 0.719, "exchangeTimezoneName": "Europe/Stockholm", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "exchange": "STO", "shortName": "Cyxone AB", "longName": "Cyxone AB (publ)", "messageBoardId": "finmb_330187969", "market": "se_market", "symbol": "CYXO.ST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Adelgatan 21", "city": "Malm\u00f6", "zip": "221 22", "country": "Sweden", "phone": "46 7 08 88 21 72", "website": "https://www.cyxone.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Cyxone AB (publ), a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis, multiple sclerosis, and treatments for virally induced acute respiratory disorders. Its development portfolio comprises Rabeximod in a clinical Phase II program for rheumatoid arthritis and Covid-19 infections; and T20K, a Phase 1 candidate drug for the treatment of multiple sclerosis. The company was incorporated in 2015 and is based in Malm\u00f6, Sweden.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Mr. Carl-Magnus  Hogerkorp", "age": 52, "title": "CEO & Director", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ola  Skanung", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2020, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Erika  Samuelsson", "age": 46, "title": "Chief Devel. Officer", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1609372800, "maxAge": 86400}}], "error": null}}